| Watford City Chiropractic | |
|
105 9th Ave Se, Watford City, ND 58854-0589 | |
| (406) 600-5039 | |
| Not Available |
| Full Name | Watford City Chiropractic |
|---|---|
| Type | Facility |
| Speciality | Chiropractor |
| Location | 105 9th Ave Se, Watford City, North Dakota |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063832137 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | (* (Not Available)) | Primary |
| Provider Name | Travis J Myers |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1912182544 PECOS PAC ID: 1557447646 Enrollment ID: I20100503000208 |
News Archive
Following today's introduction of a health care reform plan by Senate Finance Committee Chairman Max Baucus (D-MT), Joe Jackson, chairman of Save Flexible Spending Plans and CEO of WageWorks, a benefits company based in San Mateo, California, issued the following statement:
VIVUS, Inc. (Nasdaq: VVUS) today announced positive results from two final, phase 3 pivotal 56-week studies, EQUIP (OB-302) and CONQUER (OB-303), evaluating the safety and efficacy of Qnexa(TM), an investigational drug, in more than 3,750 patients across 93 sites. The EQUIP and CONQUER studies met all primary endpoints by demonstrating statistically significant weight loss with all three doses of Qnexa, as compared to placebo.
As the stock market plunged, President Barack Obama said the nation's deficit couldn't be ignored. He recommended an approach that includes spending cuts as well as increased tax revenue and "modest adjustments" to health care programs. Meanwhile, health care stocks were among those that posted double-digit losses, and, as the fallout from S & P's downgrade continues, some states are at more risk than others.
BioSimulytics (www.biosimulytics.ai), a University College Dublin (UCD) spin-out company, today announced that it has secured €595k in initial seed funding from a number of strategic angel investors and Enterprise Ireland.
Researchers from Nottingham have played their part in the discovery of a rare genetic mutation that increases the risk of Alzheimer's disease, in a study with major implications for understanding the causes of the disease.
› Verified 2 days ago
| Provider Name | Aaron B Patchen |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1437497625 PECOS PAC ID: 3577709492 Enrollment ID: I20130422000071 |
News Archive
Following today's introduction of a health care reform plan by Senate Finance Committee Chairman Max Baucus (D-MT), Joe Jackson, chairman of Save Flexible Spending Plans and CEO of WageWorks, a benefits company based in San Mateo, California, issued the following statement:
VIVUS, Inc. (Nasdaq: VVUS) today announced positive results from two final, phase 3 pivotal 56-week studies, EQUIP (OB-302) and CONQUER (OB-303), evaluating the safety and efficacy of Qnexa(TM), an investigational drug, in more than 3,750 patients across 93 sites. The EQUIP and CONQUER studies met all primary endpoints by demonstrating statistically significant weight loss with all three doses of Qnexa, as compared to placebo.
As the stock market plunged, President Barack Obama said the nation's deficit couldn't be ignored. He recommended an approach that includes spending cuts as well as increased tax revenue and "modest adjustments" to health care programs. Meanwhile, health care stocks were among those that posted double-digit losses, and, as the fallout from S & P's downgrade continues, some states are at more risk than others.
BioSimulytics (www.biosimulytics.ai), a University College Dublin (UCD) spin-out company, today announced that it has secured €595k in initial seed funding from a number of strategic angel investors and Enterprise Ireland.
Researchers from Nottingham have played their part in the discovery of a rare genetic mutation that increases the risk of Alzheimer's disease, in a study with major implications for understanding the causes of the disease.
› Verified 2 days ago
| Provider Name | Wade A Darr |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1003972571 PECOS PAC ID: 6204880057 Enrollment ID: I20140825002766 |
News Archive
Following today's introduction of a health care reform plan by Senate Finance Committee Chairman Max Baucus (D-MT), Joe Jackson, chairman of Save Flexible Spending Plans and CEO of WageWorks, a benefits company based in San Mateo, California, issued the following statement:
VIVUS, Inc. (Nasdaq: VVUS) today announced positive results from two final, phase 3 pivotal 56-week studies, EQUIP (OB-302) and CONQUER (OB-303), evaluating the safety and efficacy of Qnexa(TM), an investigational drug, in more than 3,750 patients across 93 sites. The EQUIP and CONQUER studies met all primary endpoints by demonstrating statistically significant weight loss with all three doses of Qnexa, as compared to placebo.
As the stock market plunged, President Barack Obama said the nation's deficit couldn't be ignored. He recommended an approach that includes spending cuts as well as increased tax revenue and "modest adjustments" to health care programs. Meanwhile, health care stocks were among those that posted double-digit losses, and, as the fallout from S & P's downgrade continues, some states are at more risk than others.
BioSimulytics (www.biosimulytics.ai), a University College Dublin (UCD) spin-out company, today announced that it has secured €595k in initial seed funding from a number of strategic angel investors and Enterprise Ireland.
Researchers from Nottingham have played their part in the discovery of a rare genetic mutation that increases the risk of Alzheimer's disease, in a study with major implications for understanding the causes of the disease.
› Verified 2 days ago
| Provider Name | John Rotondi |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1720143423 PECOS PAC ID: 9830084417 Enrollment ID: I20141124002529 |
News Archive
Following today's introduction of a health care reform plan by Senate Finance Committee Chairman Max Baucus (D-MT), Joe Jackson, chairman of Save Flexible Spending Plans and CEO of WageWorks, a benefits company based in San Mateo, California, issued the following statement:
VIVUS, Inc. (Nasdaq: VVUS) today announced positive results from two final, phase 3 pivotal 56-week studies, EQUIP (OB-302) and CONQUER (OB-303), evaluating the safety and efficacy of Qnexa(TM), an investigational drug, in more than 3,750 patients across 93 sites. The EQUIP and CONQUER studies met all primary endpoints by demonstrating statistically significant weight loss with all three doses of Qnexa, as compared to placebo.
As the stock market plunged, President Barack Obama said the nation's deficit couldn't be ignored. He recommended an approach that includes spending cuts as well as increased tax revenue and "modest adjustments" to health care programs. Meanwhile, health care stocks were among those that posted double-digit losses, and, as the fallout from S & P's downgrade continues, some states are at more risk than others.
BioSimulytics (www.biosimulytics.ai), a University College Dublin (UCD) spin-out company, today announced that it has secured €595k in initial seed funding from a number of strategic angel investors and Enterprise Ireland.
Researchers from Nottingham have played their part in the discovery of a rare genetic mutation that increases the risk of Alzheimer's disease, in a study with major implications for understanding the causes of the disease.
› Verified 2 days ago
| Provider Name | Amy L Klein |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1780051706 PECOS PAC ID: 9436467396 Enrollment ID: I20150928000590 |
News Archive
Following today's introduction of a health care reform plan by Senate Finance Committee Chairman Max Baucus (D-MT), Joe Jackson, chairman of Save Flexible Spending Plans and CEO of WageWorks, a benefits company based in San Mateo, California, issued the following statement:
VIVUS, Inc. (Nasdaq: VVUS) today announced positive results from two final, phase 3 pivotal 56-week studies, EQUIP (OB-302) and CONQUER (OB-303), evaluating the safety and efficacy of Qnexa(TM), an investigational drug, in more than 3,750 patients across 93 sites. The EQUIP and CONQUER studies met all primary endpoints by demonstrating statistically significant weight loss with all three doses of Qnexa, as compared to placebo.
As the stock market plunged, President Barack Obama said the nation's deficit couldn't be ignored. He recommended an approach that includes spending cuts as well as increased tax revenue and "modest adjustments" to health care programs. Meanwhile, health care stocks were among those that posted double-digit losses, and, as the fallout from S & P's downgrade continues, some states are at more risk than others.
BioSimulytics (www.biosimulytics.ai), a University College Dublin (UCD) spin-out company, today announced that it has secured €595k in initial seed funding from a number of strategic angel investors and Enterprise Ireland.
Researchers from Nottingham have played their part in the discovery of a rare genetic mutation that increases the risk of Alzheimer's disease, in a study with major implications for understanding the causes of the disease.
› Verified 2 days ago
| Provider Name | Curtis G Wright |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1023124567 PECOS PAC ID: 4183812688 Enrollment ID: I20160224002198 |
News Archive
Following today's introduction of a health care reform plan by Senate Finance Committee Chairman Max Baucus (D-MT), Joe Jackson, chairman of Save Flexible Spending Plans and CEO of WageWorks, a benefits company based in San Mateo, California, issued the following statement:
VIVUS, Inc. (Nasdaq: VVUS) today announced positive results from two final, phase 3 pivotal 56-week studies, EQUIP (OB-302) and CONQUER (OB-303), evaluating the safety and efficacy of Qnexa(TM), an investigational drug, in more than 3,750 patients across 93 sites. The EQUIP and CONQUER studies met all primary endpoints by demonstrating statistically significant weight loss with all three doses of Qnexa, as compared to placebo.
As the stock market plunged, President Barack Obama said the nation's deficit couldn't be ignored. He recommended an approach that includes spending cuts as well as increased tax revenue and "modest adjustments" to health care programs. Meanwhile, health care stocks were among those that posted double-digit losses, and, as the fallout from S & P's downgrade continues, some states are at more risk than others.
BioSimulytics (www.biosimulytics.ai), a University College Dublin (UCD) spin-out company, today announced that it has secured €595k in initial seed funding from a number of strategic angel investors and Enterprise Ireland.
Researchers from Nottingham have played their part in the discovery of a rare genetic mutation that increases the risk of Alzheimer's disease, in a study with major implications for understanding the causes of the disease.
› Verified 2 days ago
| Provider Name | Tanner Parizek |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1588006738 PECOS PAC ID: 7810275716 Enrollment ID: I20161027001774 |
News Archive
Following today's introduction of a health care reform plan by Senate Finance Committee Chairman Max Baucus (D-MT), Joe Jackson, chairman of Save Flexible Spending Plans and CEO of WageWorks, a benefits company based in San Mateo, California, issued the following statement:
VIVUS, Inc. (Nasdaq: VVUS) today announced positive results from two final, phase 3 pivotal 56-week studies, EQUIP (OB-302) and CONQUER (OB-303), evaluating the safety and efficacy of Qnexa(TM), an investigational drug, in more than 3,750 patients across 93 sites. The EQUIP and CONQUER studies met all primary endpoints by demonstrating statistically significant weight loss with all three doses of Qnexa, as compared to placebo.
As the stock market plunged, President Barack Obama said the nation's deficit couldn't be ignored. He recommended an approach that includes spending cuts as well as increased tax revenue and "modest adjustments" to health care programs. Meanwhile, health care stocks were among those that posted double-digit losses, and, as the fallout from S & P's downgrade continues, some states are at more risk than others.
BioSimulytics (www.biosimulytics.ai), a University College Dublin (UCD) spin-out company, today announced that it has secured €595k in initial seed funding from a number of strategic angel investors and Enterprise Ireland.
Researchers from Nottingham have played their part in the discovery of a rare genetic mutation that increases the risk of Alzheimer's disease, in a study with major implications for understanding the causes of the disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Watford City Chiropractic 105 9th Ave Se, Watford City, ND 58854-0589 Ph: (406) 600-5039 | Watford City Chiropractic 105 9th Ave Se, Watford City, ND 58854-0589 Ph: (406) 600-5039 |
News Archive
Following today's introduction of a health care reform plan by Senate Finance Committee Chairman Max Baucus (D-MT), Joe Jackson, chairman of Save Flexible Spending Plans and CEO of WageWorks, a benefits company based in San Mateo, California, issued the following statement:
VIVUS, Inc. (Nasdaq: VVUS) today announced positive results from two final, phase 3 pivotal 56-week studies, EQUIP (OB-302) and CONQUER (OB-303), evaluating the safety and efficacy of Qnexa(TM), an investigational drug, in more than 3,750 patients across 93 sites. The EQUIP and CONQUER studies met all primary endpoints by demonstrating statistically significant weight loss with all three doses of Qnexa, as compared to placebo.
As the stock market plunged, President Barack Obama said the nation's deficit couldn't be ignored. He recommended an approach that includes spending cuts as well as increased tax revenue and "modest adjustments" to health care programs. Meanwhile, health care stocks were among those that posted double-digit losses, and, as the fallout from S & P's downgrade continues, some states are at more risk than others.
BioSimulytics (www.biosimulytics.ai), a University College Dublin (UCD) spin-out company, today announced that it has secured €595k in initial seed funding from a number of strategic angel investors and Enterprise Ireland.
Researchers from Nottingham have played their part in the discovery of a rare genetic mutation that increases the risk of Alzheimer's disease, in a study with major implications for understanding the causes of the disease.
› Verified 2 days ago
Dr. Aaron Burke Patchen, Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 105 9th Ave Se, Ste 3, Watford City, ND 58854 Phone: 701-842-3100 | |
Myers Chiropractic Pllc Chiropractor Medicare: Medicare Enrolled Practice Location: 113 6th Ave Se Ste 5400, Watford City, ND 58854 Phone: 701-842-3100 | |
Aligned Family Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 710 N Main St Ste 1, Watford City, ND 58854 Phone: 701-842-4300 Fax: 701-842-4446 | |
Dr. Gary L Trauger, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 105 2nd Ave Ne, Watford City, ND 58854 Phone: 701-842-2918 | |
Mrs. Amy Lynn Klein, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 710 N Main St Ste 1, Watford City, ND 58854 Phone: 701-842-4300 |